Tiers name what a vendor publishes, not a verdict on any product's purity or quality.
Lab-verifiable COAs: certificates that open on the testing lab's own site (the seal's ring shows what share of them do).
Third-party COAs: certificates attributed to a third-party lab, which may be hosted only on the vendor's site.
Tiers follow the Vendor Score (90+ and 80–89), which is 87% COA evidence; the numeral in each seal is that score.
Affiliate relationships never affect tiers, selection or order. How the Vendor Score works
Cagrilintide is an amylin analog researched in laboratory settings for its potential role in metabolic and appetite-regulating pathways. This peptide is studied primarily for its effects on satiety signaling and energy balance in preclinical models.
Evidence brief
Cagrilintide is an investigational long-acting amylin analogue studied for weight management; the main standalone human data is a phase 2, dose-finding randomized trial.
Compare by exact vialThe small sealed glass container a compound ships in.The small sealed glass container a compound ships in. size:
5mg (25 vendors)10mg (34 vendors)
Investigational — not approved. As CagriSema (with semaglutide), Novo Nordisk filed an FDA application in Dec 2025; a decision is expected around late 2026.Research use only — not medical advice.
Size, form & budget
Price includes the displayed code where available. Shipping and tax are extra. Unknown sizes or prices are excluded when those filters are set.
Your comparison
Selections stay on this browser. Prices and stock come from the current page; review freshness and COA notes for each offer. Scroll sideways to see every offer.
Select up to four offers to compare side by side. Click a column heading to sort. Click again to reverse. Scroll sideways for more columns.
Cagrilintide · all tracked vendors · all tracked peptide listings, including out-of-stock products. Prices and stock reflect the last check. Non-comparable products do not enter market rankings. Trust scores measure published evidence, not product safety.
No matches. Try another search or reset the filters.
COACertificate of Analysis: a lab report stating a batch's measured identity and purity.Certificate of Analysis: a lab report stating a batch's measured identity and purity. availability: 46 of 53 tracked sources for Cagrilintide publish a COA
— 37 with at least one certificate you can open at the testing lab: Modern Research Peptides (276 at the lab), Iron Aminos (250 at the lab), EZ Peptides (136 at the lab), Peptide Partners (133 at the lab), Ameano Peptides (108 at the lab), RUO.bio (91 at the lab), Nationwide Peptides (88 at the lab), Nexaph (88 at the lab), NuScience Peptides (87 at the lab), Feel Good Peptides (82 at the lab), Paramount Peptides (81 at the lab), MOG Labs (78 at the lab), and 34 more — every one of them is a linked row in the table above. What a COA proves →
Multi-peptide products (e.g. BPC-157 + TB-500). We don't rank these by $/mgPrice divided by the milligrams of active compound — the like-for-like way to compare cost across different vial sizes.Price divided by the milligrams of active compound — the like-for-like way to compare cost across different vial sizes. — a per-milligram figure across different peptides isn't comparable — so they're listed separately by total price and kept out of the headline index above.
Cagrilintide is an investigational long-acting amylin analogue studied for weight management; the main standalone human data is a phase 2, dose-finding randomized trial.
"Are peptides safe?" has no single answer. The compounds sold as research peptides sit at very different points on the evidence scale, from large randomized human trials for a few to animal-only data for many.
Source-linked reference figures with the population and study context alongside each amount. Study arms are not a starting dose, titration schedule, or personal treatment plan. Label records refer to the named approved medicine, not vendor products.
Dose administered in a phase 2 dose-finding randomised trial (human, adults without diabetes with a body-mass index of at least 30 kg/m2, or at least 27 kg/m2 with hypertension or dyslipidaemia)
0.3 mg once weekly, 0.6 mg once weekly, 1.2 mg once weekly, 2.4 mg once weekly, or 4.5 mg once weekly
human · adults without diabetes with a body-mass index of at least 30 kg/m2, or at least 27 kg/m2 with hypertension or dyslipidaemia · phase 2 dose-finding randomised trial · Route reported: subcutaneous
Research use only — this reports what an FDA label or a peer-reviewed study published, tied to its species and study context. It is not medical advice, not a recommendation to use, and no dose here is generated by pepmg. Any dosing decision is for a qualified professional. Animal-study amounts do not establish a human dose.
Reconstitution calculator → · Converts your entered quantities; it does not select a dose or establish suitability for use.
● Peer-reviewed research · Cagrilintidesource: PubMed
Natural amylin is a pancreatic hormone that induces satiety. Cagrilintide is a long-acting amylin analogue under investigation for weight management. We assessed the dose-response relationship of cagrilintide regarding the effects on…
RCThumanThe New England journal of medicine · 2025 · PMID 40544433
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the combination (known as CagriSema) on weight…
StudyhumanJournal of medicinal chemistry · 2021 · PMID 34288673
A hallmark of the pancreatic hormone amylin is its high propensity toward the formation of amyloid fibrils, which makes it a challenging drug design effort. The amylin analogue pramlintide is commercially available for diabetes treatment…
A few representative studies, each summarized on this site with the PubMed record linked beside it — not an endorsement or a claim that any result applies to human use. Read them and judge for yourself. Everything here is research use only.
Per-mg prices for Cagrilintide vary significantly between vendors due to differences in synthesis scale, purity verification, and batch consistency. Comparing prices helps researchers identify cost-effective sources while ensuring the compound meets their research-grade specifications.
▸ Reading the COA
For Cagrilintide, a Certificate of Analysis should confirm identity via mass spectrometry and purity by HPLC, typically above 98%. Check for common adulterants like residual solvents or truncated peptide fragments, and verify that the stated mass matches the actual fill weight to avoid under-filling.
▸ FAQ
How should Cagrilintide be stored for research purposes?
Store lyophilized Cagrilintide in a freezer at -20°C, protected from light and moisture, to maintain stability. Reconstituted solutions should be kept refrigerated and used promptly to avoid degradation.
What is a Certificate of Analysis (COA) and why is it important?
A COA is a document from the vendor or third-party lab that verifies the peptide's identity, purity, and concentration. It is crucial for confirming that the compound meets research-grade standards and is free from contaminants.
Why do prices for Cagrilintide differ so much between suppliers?
Price differences stem from factors like synthesis methods, scale of production, quality control testing, and purity levels. Higher-priced vendors often invest in rigorous third-party analytics, while lower prices may reflect less stringent processing.
All products listed are sold by third-party vendors for laboratory and research use only (RUO). Where an FDA label or a peer-reviewed study has published a dose, pepmg reports it with the source named, because that is safer than guessing. It is a report, not medical advice and not a recommendation to use anything. pepmg sells nothing and ships nothing. Listings are price-tracking data, not endorsements.
✓
＋ Get the free Weekly Price Index One email a week — where every compound's $/mg moved. No spam.
